Detalhe da pesquisa
1.
Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology.
J Am Chem Soc;
141(39): 15700-15709, 2019 10 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31497954
2.
TAM family kinases as therapeutic targets at the interface of cancer and immunity.
Nat Rev Clin Oncol;
20(11): 755-779, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37667010
3.
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer.
J Clin Invest;
132(15)2022 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35708914
4.
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system.
Pharmacol Ther;
213: 107577, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32417270
5.
Corrigendum to "MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system" [Pharmacology & Therapeutics 213 (2020) 107577].
Pharmacol Ther;
225: 107822, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33714535